UAB researchers have launched DiaClue, a free web-based tool that helps clinicians classify diabetes into five subtypes, ...
The study, titled “GenAI-Powered Framework for Reliable Sentiment Labeling in Drug Safety Monitoring,” published in Applied ...
Explore how AI in high-throughput screening improves drug discovery through advanced data analysis, hit identification and ...
In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...
April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma Predicting severe adverse events (SAEs) in oncology is ...
TORONTO--(BUSINESS WIRE)--The first patient has been treated in a unique clinical trial to evaluate the safety and efficacy of a novel pharmacologic intervention aimed at preventing acute ischemic ...
Since its introduction nine months ago, the FDA’s national priority voucher pilot program has attracted intrigue and fierce criticism while also yielding several rapid drug approvals. With all of this ...
A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...
EXCLUSIVE: The White House is expecting to announce an expansion of drugmakers offering discounts on TrumpRx.gov, FOX Business has learned. As early as today, Amgen and GSK will be added to the list ...
The prescription drug leucovorin is getting a label update, but it’s not what that the US Food and Drug Administration suggested during a White House briefing in September, when officials touted the ...
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results